Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10419882 | 0.97 | GART (0.80) | GARTATIC | |
| SCHEMBL10420648 | 0.97 | GART (0.77) | GARTATIC | |
| SCHEMBL9687525 | 0.97 | GART (0.74) | GARTATIC | |
| SCHEMBL10419875 | 0.97 | GART (0.74) | GARTATIC | |
| SCHEMBL9687628 | 0.94 | GART (0.75) | GARTATIC | |
| SCHEMBL9688385 | 0.94 | GART (0.70) | GARTATIC | |
| SCHEMBL10419878 | 0.93 | GART (0.70) | GARTATIC | |
| SCHEMBL9687536 | 0.93 | GART (0.70) | GARTATIC | |
| SCHEMBL10521244 | 0.89 | GART (0.71) | GARTATIC | |
| SCHEMBL9687649 | 0.88 | GART (0.66) | GARTATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0268377-B1 | GLUTAMIC ACID DERIVATIVES, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-03-18 | — | — | EP | claimed |
| US-4880812-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-11-14 | — | — | US | claimed |
| EP-4720100-A1 | MODIFIED VECTORS | CSL Behring LLC (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250354166-A1 | LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE | CSL BEHRING L L C (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4190339-B1 | A MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | CSL BEHRING GENE THERAPY INC (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024241281-A1 | MODIFIED VECTORS | CSL BEHRING L.L.C. (US) | 2024-11-28 | — | — | WO | disclosed |
| CN-118103076-A | Lentiviral vectors useful in the treatment of disease | 美国杰特贝林生物制品有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4329822-A1 | LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE | CSL Behring L.L.C. (US) | 2024-03-06 | — | — | EP | disclosed |
| US-20230355674-A1 | DONOR T-CELLS WITH KILL SWITCH | CSL BEHRING LLC (US) | 2023-11-09 | — | — | US | disclosed |
| EP-4190339-A1 | A MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | CSL Behring Gene Therapy, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-4172335-A1 | DONOR T-CELLS WITH KILL SWITCH | CSL Behring LLC (US) | 2023-05-03 | — | — | EP | disclosed |
| CN-115997015-A | Donor T cells with kill switch | 美国杰特贝林生物制品有限公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-3654994-B1 | A MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | CSL BEHRING GENE THERAPY INC (US) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022232191-A1 | LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE | CSL BEHRING L.L.C. (US) | 2022-11-03 | — | — | WO | disclosed |
| US-20220072046-A1 | MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS | CSL BEHRING GENE THERAPY INC (US) | 2022-03-10 | — | — | US | disclosed |
| EP-0268377-B1 | GLUTAMIC ACID DERIVATIVES, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-03-18 | — | — | EP | disclosed |
| US-4940713-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1990-07-10 | — | — | US | disclosed |
| US-4880812-A | ANTITUMOR AGENTS | BURROUGHS WELLCOME CO. (US) | 1989-11-14 | — | — | US | disclosed |
| EP-0268377-A2 | Glutamic acid derivatives, processes and intermediates for their preparation and pharmaceutical formulations containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-05-25 | — | — | EP | disclosed |